BDBM321447 N,N-dimethyl-3-[6-(3-methylbut-2-enyl)-7-oxo-1H-pyrrolo[2,3-c]pyridin-4-yl]benzamide::US10183009, Example 3
SMILES: CN(C)C(=O)c1cccc(c1)-c1cn(CC=C(C)C)c(=O)c2[nH]ccc12
InChI Key: InChIKey=DMDKQAYAEKHHCQ-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CECR2 (aa 424-538) (Homo sapiens (Human)) | BDBM321447![]() (N,N-dimethyl-3-[6-(3-methylbut-2-enyl)-7-oxo-1H-py...) | PDB GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged TAF1-BD21504-1635 was cloned, expressed, and purified to homogeneity. TAF1-BD2 binding and inhibition was assessed by monitor... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair |